Showing 1 - 17 results of 17 for search 'Szymon Zmorzynski', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
<i>WT1</i> Gene Mutations, rs16754 Variant, and <i>WT1</i> Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients by Dorota Koczkodaj, Szymon Zmorzyński, Beata Grygalewicz, Barbara Pieńkowska-Grela, Wojciech Styk, Sylwia Popek-Marciniec, Agata Anna Filip
Published 2022-03-01
Article -
10
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma by Szymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, Wojciech Styk, Sylwia Chocholska, Agata Anna Filip
Published 2021-11-01
Article -
11
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Ac... by Szymon Zmorzynski, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
Published 2024-03-01
Article -
12
Influence of Algae Supplementation on the Concentration of Glutathione and the Activity of Glutathione Enzymes in the Mice Liver and Kidney by Grażyna Świderska-Kołacz, Małgorzata Jefimow, Jolanta Klusek, Norbert Rączka, Szymon Zmorzyński, Anna Wojciechowska, Iwona Stanisławska, Marek Łyp, Joanna Czerwik-Marcinkowska
Published 2021-06-01
Article -
13
The Relationship of <i>CCL5</i> and <i>CCR1</i> Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma by Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
Published 2023-03-01
Article -
14
Association of Chromosome 17 Aneuploidy, <i>TP53</i> Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment by Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Sylwia Chocholska, Aneta Szudy-Szczyrek, Marzena Samardakiewicz, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
Published 2023-09-01
Article -
15
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma by Szymon Zmorzyński, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, Magdalena Wojcierowska-Litwin, Iwona Korszeń-Pilecka, Sylwia Chocholska, Wojciech Styk, Marek Hus, Agata A. Filip
Published 2019-10-01
Article -
16
The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development by Joanna Bartosińska, Szymon Zmorzyński, Beata Sarecka-Hujar, Dorota Raczkiewicz, Magdalena Wojcierowska-Litwin, Iwona Korszeń-Pilecka, Anna Michalak-Stoma, Małgorzata Kowal, Jarosław Bartosiński, Agata Filip, Dorota Krasowska, Grażyna Chodorowska
Published 2021-08-01
Article -
17
ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma by Szymon Zmorzynski, Aneta Szudy-Szczyrek, Sylwia Popek-Marciniec, Iwona Korszen-Pilecka, Magdalena Wojcierowska-Litwin, Małgorzata Luterek, Sylwia Chocholska, Wojciech Styk, Grazyna Swiderska-Kołacz, Joanna Januszewska, Michal Mielnik, Marek Hus, Agata A. Filip
Published 2019-02-01
Article